Biosimilars—a fast-growing class of therapeutic products that are highly similar to and have no clinically meaningful differences from existing FDA-approved branded biologics—are poised to bring significant cost savings opportunities in oncology, while maintaining high quality patient care. While some providers are actively using biosimilars in patient care, others feel challenged with navigating the economic , clinical and operational implications of adopting biosimilars.
In this webinar discussion hosted with Oncology Practice Management, learn about the key challenges and real-life best practices for biosimilar adoption, including how tools, processes and expert support from VitalSourceTM GPO help practices navigate the dynamic and rapidly evolving landscape.
In this webinar, you will learn:
- Current U.S. biosimilar market dynamics
- Barriers and challenges to biosimilar adoption in oncology
- Real world strategies for successful implementation of biosimilars in oncology practices
- Resources and tools available through VitalSourceTM GPO to support the evaluation and adoption of biosimilars
Sonia T. Oskouei
PharmD, BCMAS, DPLA
VP, Biosimilars, Cardinal Health
Director, Practice Consulting
Lead Clinical Pharmacy Specialist
Live webinar occurred on February 9, 2021.